The Primary Care Companion for CNS Disorders, 23 (4), 20m02747
The FDA has approved specific formulations for different indications: semaglutide 2.4 mg (Wegovy), liraglutide 3 mg (Saxenda), and tirzepatide (Zepbound) are approved for chronic weight management, while all are approved for diabetes at different doses
Persistent fatigue even when your thyroid levels are "within range." If fatigue is one of your biggest symptoms, our article on why an underactive thyroid can make you tired explains why this can happen
[25] Your GP can advise on referral pathways and which options are appropriate for your individual circumstances
[1] The Medicines and Healthcare products Regulatory Agency (MHRA) has approved its use in the UK, and it must be prescribed by a qualified healthcare professional as part of a comprehensive treatment plan that includes dietary modifications and increased physical activity
Nasal Spray: For those who prefer a non-invasive option, PT-141 is also available as a nasal spray